Pilot Study of Liposomal Bupivacaine Redosing in Patients Undergoing Major Gynecologic Procedures
Status:
Recruiting
Trial end date:
2022-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this research study is to find out which type of transversus abdomens plane
(TAP) and block (bupivacaine, liposomal bupivacaine or liposomal bupivacaine with re-dosing
at 48-60 hours) improves your pain control and lowers your risk of post-operative common side
effects of surgery and narcotic pain medications.